Matthew Binns

Company: UCB

Job title: Access & Pricing Leader, Neurology & Rare Diseases

Seminars:

Unlocking Commercial Pathways for Non-Oncology Precision Medicines & Diagnostics to Accelerate Market Entry 2:10 pm

What steps are essential for analytical and clinical validation in non-oncology diagnostics? Optimising commercial and launch planning outside oncology to corroborate timely medicinal product and CDx approvals How can labs optimise processes for non-oncology diagnostics in areas like sample acquisition, network setup, turnaround time, and reliable result delivery?Read more

day: Day 2 - Track B (2)